NanoViricides, Inc. (NNVC)
1.05
-0.03
(-2.78%)
USD |
NYAM |
Sep 09, 16:00
1.05
0.00 (0.00%)
After-Hours: 17:07
NanoViricides Shareholders Equity (Quarterly) : 9.154M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 9.154M |
| December 31, 2025 | 11.07M |
| September 30, 2025 | 7.175M |
| June 30, 2025 | 7.518M |
| March 31, 2025 | 8.833M |
| December 31, 2024 | 10.39M |
| September 30, 2024 | 10.11M |
| June 30, 2024 | 11.46M |
| March 31, 2024 | 10.65M |
| December 31, 2023 | 12.45M |
| September 30, 2023 | 12.97M |
| June 30, 2023 | 14.87M |
| March 31, 2023 | 18.23M |
| December 31, 2022 | 19.87M |
| September 30, 2022 | 21.56M |
| June 30, 2022 | 23.08M |
| March 31, 2022 | 24.76M |
| December 31, 2021 | 26.47M |
| September 30, 2021 | 28.31M |
| June 30, 2021 | 29.91M |
| March 31, 2021 | 31.89M |
| December 31, 2020 | 27.75M |
| September 30, 2020 | 29.98M |
| June 30, 2020 | 21.76M |
| March 31, 2020 | 14.31M |
| Date | Value |
|---|---|
| December 31, 2019 | 7.722M |
| September 30, 2019 | 9.130M |
| June 30, 2019 | 10.60M |
| March 31, 2019 | 12.72M |
| December 31, 2018 | 13.84M |
| September 30, 2018 | 15.98M |
| June 30, 2018 | 17.66M |
| March 31, 2018 | 19.15M |
| December 31, 2017 | 15.92M |
| September 30, 2017 | 18.52M |
| June 30, 2017 | 20.32M |
| March 31, 2017 | 22.41M |
| December 31, 2016 | 19.15M |
| September 30, 2016 | 20.23M |
| June 30, 2016 | 23.05M |
| March 31, 2016 | 23.98M |
| December 31, 2015 | 28.38M |
| September 30, 2015 | 30.71M |
| June 30, 2015 | 31.79M |
| March 31, 2015 | 31.86M |
| December 31, 2014 | 30.51M |
| September 30, 2014 | 36.83M |
| June 30, 2014 | 23.37M |
| March 31, 2014 | 32.03M |
| December 31, 2013 | 10.21M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.22M |
| Total Liabilities (Quarterly) | 1.065M |
| Current Ratio | 3.170 |